Cargando…
An investigation into human papillomavirus (HPV) vaccination for patients undergoing surgery for high-grade cervical or vulvar dysplasia
INTRODUCTION: Eligibility for the human papillomavirus (HPV) vaccine now includes adults 27 through 45 years. It has not been reported how providers are addressing HPV vaccination in patients with existing preinvasive disease. Our objectives were to determine the rates at which vaccination is offere...
Autores principales: | Boyles, Glenn P., Baek, Jae, Pandit, Radhika, Cosgrove, Casey M., Bixel, Kristin L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9120215/ https://www.ncbi.nlm.nih.gov/pubmed/35603128 http://dx.doi.org/10.1016/j.gore.2022.101001 |
Ejemplares similares
-
Wound complications following vulvar excision for nonmalignant lesions
por: Boyles, Glenn P., et al.
Publicado: (2021) -
The role of human papillomavirus testing after treatment for high-grade cervical dysplasia
por: Turner, Taylor B, et al.
Publicado: (2016) -
Outcomes of High-Grade Cervical Dysplasia with Positive Margins and HPV Persistence after Cervical Conization
por: Giannini, Andrea, et al.
Publicado: (2023) -
Effect of the human papillomavirus (HPV) quadrivalent vaccine in a subgroup of women with cervical and vulvar disease: retrospective pooled analysis of trial data
por: Joura, Elmar A, et al.
Publicado: (2012) -
HPV immunohistochemical testing and cervical dysplasia
por: MUREŞAN, DANIEL, et al.
Publicado: (2016)